Cargando…

Brain Metastasis in Pancreatic Cancer

Pancreatic cancer is a fatal disease with a 5-year survival rate below 5%. Most patients are diagnosed at an advanced tumor stage and existence of distant metastases. However, involvement of the central nervous system is rare in pancreatic cancer. We retrospectively analyzed all cases of brain metas...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemke, Johannes, Scheele, Jan, Kapapa, Thomas, Wirtz, Christian Rainer, Henne-Bruns, Doris, Kornmann, Marko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3588092/
https://www.ncbi.nlm.nih.gov/pubmed/23429199
http://dx.doi.org/10.3390/ijms14024163
_version_ 1782261497482706944
author Lemke, Johannes
Scheele, Jan
Kapapa, Thomas
Wirtz, Christian Rainer
Henne-Bruns, Doris
Kornmann, Marko
author_facet Lemke, Johannes
Scheele, Jan
Kapapa, Thomas
Wirtz, Christian Rainer
Henne-Bruns, Doris
Kornmann, Marko
author_sort Lemke, Johannes
collection PubMed
description Pancreatic cancer is a fatal disease with a 5-year survival rate below 5%. Most patients are diagnosed at an advanced tumor stage and existence of distant metastases. However, involvement of the central nervous system is rare in pancreatic cancer. We retrospectively analyzed all cases of brain metastases in pancreatic cancer reported to date focusing on patient characteristics, clinical appearance, therapy and survival. Including our own, 12 cases of brain metastases originating from pancreatic cancer were identified. In three patients brain metastases were the first manifestation of pancreatic cancer. All other patients developed brain metastases during their clinical course. In most cases, the disease progressed rapidly and the patients died within weeks or months. However, two patients showed long-term survival. Of note, both patients received resection of the pancreatic cancer as well as curative resection of the metachronous brain metastases. Brain metastases in pancreatic cancer are a rare condition and usually predict a very poor prognosis. However, there is evidence that resection of brain metastases of pancreatic cancer can be immensely beneficial to patient’s survival, even with the chance for cure. Therefore, a surgical approach in metastatic pancreatic cancer should be considered in selective cases.
format Online
Article
Text
id pubmed-3588092
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-35880922013-03-13 Brain Metastasis in Pancreatic Cancer Lemke, Johannes Scheele, Jan Kapapa, Thomas Wirtz, Christian Rainer Henne-Bruns, Doris Kornmann, Marko Int J Mol Sci Review Pancreatic cancer is a fatal disease with a 5-year survival rate below 5%. Most patients are diagnosed at an advanced tumor stage and existence of distant metastases. However, involvement of the central nervous system is rare in pancreatic cancer. We retrospectively analyzed all cases of brain metastases in pancreatic cancer reported to date focusing on patient characteristics, clinical appearance, therapy and survival. Including our own, 12 cases of brain metastases originating from pancreatic cancer were identified. In three patients brain metastases were the first manifestation of pancreatic cancer. All other patients developed brain metastases during their clinical course. In most cases, the disease progressed rapidly and the patients died within weeks or months. However, two patients showed long-term survival. Of note, both patients received resection of the pancreatic cancer as well as curative resection of the metachronous brain metastases. Brain metastases in pancreatic cancer are a rare condition and usually predict a very poor prognosis. However, there is evidence that resection of brain metastases of pancreatic cancer can be immensely beneficial to patient’s survival, even with the chance for cure. Therefore, a surgical approach in metastatic pancreatic cancer should be considered in selective cases. MDPI 2013-02-19 /pmc/articles/PMC3588092/ /pubmed/23429199 http://dx.doi.org/10.3390/ijms14024163 Text en © 2013 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Lemke, Johannes
Scheele, Jan
Kapapa, Thomas
Wirtz, Christian Rainer
Henne-Bruns, Doris
Kornmann, Marko
Brain Metastasis in Pancreatic Cancer
title Brain Metastasis in Pancreatic Cancer
title_full Brain Metastasis in Pancreatic Cancer
title_fullStr Brain Metastasis in Pancreatic Cancer
title_full_unstemmed Brain Metastasis in Pancreatic Cancer
title_short Brain Metastasis in Pancreatic Cancer
title_sort brain metastasis in pancreatic cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3588092/
https://www.ncbi.nlm.nih.gov/pubmed/23429199
http://dx.doi.org/10.3390/ijms14024163
work_keys_str_mv AT lemkejohannes brainmetastasisinpancreaticcancer
AT scheelejan brainmetastasisinpancreaticcancer
AT kapapathomas brainmetastasisinpancreaticcancer
AT wirtzchristianrainer brainmetastasisinpancreaticcancer
AT hennebrunsdoris brainmetastasisinpancreaticcancer
AT kornmannmarko brainmetastasisinpancreaticcancer